Review shows that antidepressants have significant effect when treating generalized anxiety disorder.

Study investigates why vial choices matters for frozen biopharmaceutical storage.

Senate committee votes in favor of the nomination; full Senate vote will be next.

With new cases of avian influenza appearing, what does this mean for global health and what are drug developers doing about it?

The Trump administration’s move to pause federal funding while projects are vetted causes concern and lawsuits

Watch our video interview covering Claus Zieler’s career and passion for improving investment in Europe.

Welcome back to our interview series with Jon Thomas, President and CEO of the California Institute for Regenerative Medicine: CIRM.

Trump withdraws the US from the WHO and pharma stakeholders call for changes to price negotiation program

Jon Thomas, CEO of CIRM, discusses the evolution of stem cell research and the future of regenerative medicine in this interview.

Unethical practices and forced labor exist in HPMC supply chains. Here’s what can be done about it.